Ambu A/S (ADR)
General ticker "AMBBY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $3.3B (TTM average)
Ambu A/S (ADR) does not follow the US Stock Market performance with the rate: -29.6%.
Estimated limits based on current volatility of 1.9%: low 10.08$, high 10.46$
Factors to consider:
- Company pays dividends (annually): last record date 2025-12-05, amount 0.06$ (Y0.59%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [10.49$, 17.61$]
- 2026-09-30 to 2027-09-30 estimated range: [10.98$, 18.19$]
Financial Metrics affecting the AMBBY estimates:
- Positive: with PPE of 45.0 at the end of fiscal year the price was neutral
- Positive: 11.29 < Operating profit margin, % of 12.99
- Positive: 2.37 < Operating cash flow per share per price, % of 2.88
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -1.40 <= -1.23
- Positive: -51.61 < Industry operating profit margin (median), % of -34.01
- Positive: 69.38 < Shareholder equity ratio, % of 78.63 <= 81.92
- Negative: -0.92 < Industry inventory ratio change (median), % of -0.68
- Negative: 0.07 < Interest expense per share per price, % of 0.11
- Negative: 1.34 < Inventory ratio change, % of 1.65
Short-term AMBBY quotes
Long-term AMBBY plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | DKK4,775.00MM | DKK5,391.00MM | DKK5,686.00MM |
| Operating Expenses | DKK4,473.00MM | DKK4,746.00MM | DKK4,947.56MM |
| Operating Income | DKK302.00MM | DKK645.00MM | DKK738.45MM |
| Non-Operating Income | DKK-92.00MM | DKK-345.00MM | DKK-27.31MM |
| Interest Expense | DKK86.00MM | DKK27.00MM | DKK28.26MM |
| R&D Expense | DKK295.00MM | DKK325.00MM | DKK129.04MM |
| Income(Loss) | DKK210.00MM | DKK300.00MM | DKK711.13MM |
| Taxes | DKK42.00MM | DKK65.00MM | DKK137.52MM |
| Net Income(Loss)* | DKK168.00MM | DKK235.00MM | DKK573.61MM |
| Stockholders Equity | DKK5,393.00MM | DKK5,594.00MM | DKK6,047.00MM |
| Inventory | DKK907.00MM | DKK1,078.00MM | DKK1,275.00MM |
| Assets | DKK6,859.00MM | DKK7,154.00MM | DKK7,690.00MM |
| Operating Cash Flow | DKK518.00MM | DKK813.00MM | DKK745.04MM |
| Capital expenditure | DKK326.00MM | DKK289.00MM | DKK110.00MM |
| Investing Cash Flow | DKK-326.00MM | DKK-289.00MM | DKK-362.00MM |
| Financing Cash Flow | DKK-222.00MM | DKK-65.00MM | DKK-144.00MM |
| Earnings Per Share** | DKK0.64 | DKK0.88 | DKK2.15 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.